Importance of hERG Screening in Regulatory Drug Development Regulatory agencies emphasize cardiac safety as a key requirement for drug approval. hERG screening is a foundational component of nonclinical safety testing used to evaluate proarrhythmic risk. Data from hERG assays inform decisions regarding further cardiac evaluations, including in vivo studies and clinical ECG monitoring. Compounds showing significant hERG inhibition may require structural modification or additional safety testing. By integrating hERG screening early, developers can align with regulatory expectations and reduce development delays. Comprehensive documentation of hERG results supports transparent safety assessments. hERG screening helps ensure that only compounds with acceptable cardiac safety profiles advance to human studies. Ref - https://www.marketresearchfuture.com/reports/herg-screening-market-10386